…The Access to Medicine Index ranks 20 of the world's largest pharmaceutical companies on their efforts to make sure that medicines are made for, and reach, people in developing countries…The Access to Medicine Index 2010 identifies GlaxoSmithKline as current industry leader in improving access...Following in its footsteps are Merck, Novartis, Gilead Sciences, and Sanofi-Aventis...Pfizer moved up strongly in the ranking; Bayer, Bristol-Myers Squibb, Merck KGaA and Novo Nordisk [part of the Novo Group] were down…Also, generic drug makers, who do less research but produce low-cost off-patent drugs, now have a separate ranking. Ranbaxy Laboratories and Cipla top that list…